FDA Inspection 1206365 — Netaji Subhash Chandra Bose Cancer Hospital
The FDA completed an inspection of Netaji Subhash Chandra Bose Cancer Hospital on April 21, 2023 in Kolkata. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 21, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Kolkata (India)
Additional Details
Clinical BA/BE